2013 Innovation Marketing Pharmaceuticals 
The Horizons Tracker
SEPTEMBER 10, 2021
After all, when people could get your core offering for free, not only would that harm your income but it would discourage the industry from producing content and stifle innovation. Research from the University of Southern California explains why piracy wasn’t the death knell of innovation so many feared. Thriving creativity.
Harvard Business Review
JUNE 7, 2012
The numbers are enough to make the apple pop right out of the marketer's eye. Clearly that's not quite the target market for a new washer and dryer. for 2013, the fourth year in a row of relatively flat growth. PwC says four forces will continue to slow the rise in medical cost trend in 2013: 1. Scientific American).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
JUNE 7, 2012
The numbers are enough to make the apple pop right out of the marketer's eye. Clearly that's not quite the target market for a new washer and dryer. for 2013, the fourth year in a row of relatively flat growth. PwC says four forces will continue to slow the rise in medical cost trend in 2013: 1. Scientific American).
Harvard Business Review
MAY 20, 2014
financial services sector went from 13,000 of independent banks to half that number, while the top ten banks grew from 20% market share to 60%. As of 2013, the top ten banks had 70% of the market. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. In the guitar business , too.
Harvard Business Review
MARCH 31, 2016
” In the article, a marketing expert explains why societal shifts would render the door-to-door salesman obsolete. Over the years, innovations in distribution, media, and technology have enabled buyers to use non-sales force channels for various steps of their buying journey. ” That 1916 prediction didn’t prove true.
Harvard Business Review
NOVEMBER 27, 2013
Recent events have seen a rash of the departures from large corporates: Steve Ballmer from MicroSoft, Jeremy Levin from Teva Pharmaceutical, and Thorsten Heins from Blackberry. So it’s consistent with market forces. And a 2013 study by Xueming Luo, Vamsi K. Under her reign, on 1 November 2013, it closed at £1,498.00.
Harvard Business Review
NOVEMBER 30, 2017
A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. But now the situation has reached such a tipping point that larger U.S. manufacturers are taking notice.
Expert insights. Personalized for you.
81 
Let's personalize your content